Skip to search formSkip to main contentSkip to account menu

lenvatinib mesylate

Known as: 6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]- 7-methoxy-, methanesulfonate (1:1) 
A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with… 
National Institutes of Health

Search for papers about lenvatinib mesylate

Search papers